Abstract
The vinca alkaloids are antineoplastic indole derivatives (Fig. 1) that are isolated from the leaves of the periwinkle plant, Vinca rosea L., or more correctly, Catharanthus roseus G. Don. This plant is of Madagascan origin, although its distribution is now pantropical (Stearn, 1975). Even in varieties selected for the highest alkaloid content, the concentrations of these antitumor agents are very low, as much as 1 kg of dried leaves being needed to obtain 3 mg of vincristine, for example.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham, D.J.: Structure elucidation and chemistry of the bis catharanthus alkaloids. In: The catharanthus alkaloids, botany, chemistry, pharmacology, and clinical use. Taylor, W.I., Farnsworth, N.R. (eds.), p. 125. New York: Marcel Dekker 1975
Adelmann, M.R., Borisy, G.G., Shelanski, M.L., Weisenberg, R.C., Taylor, E.W.: Cytoplasmic filaments and tubules. Fed. Proc. 27, 1186–1193 (1968)
Agustin, B.M., Creasey, W.A.: Effects of vinca alkaloids on the synthesis of RNA in mouse brain. Nature (London) 215, 965–966 (1967)
Aisenberg, A.C.: Suppression of immune response by “vincristine” and “vinblastine”. Nature (London) 200, 484 (1963)
Anderson, P.J., Song, S.K., Slotwiner, P.: The fine structure of spheromembranous degeneration of skeletal muscle induced by vincristine. J. Neuropathol. Exp. Neurol. 26, 15–24 (1967)
Armstrong, J.G.: New derivatives of the Vinca rosea alkaloids. Acta Genet. Med. (Roma) 17, 193–196 (1968)
Armstrong, J.G., Dyke, R.W., Fouts, P.J., Hawthorne, J.J., Jansen, C.J. Jr., Peabody, A.M.: Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine. Cancer Res. 27, 221–227 (1967)
Beer, C.T.: The leukopenic action of extracts of Vinca rosea. A.R. Br. Emp. Cancer Campaign 33, 487–488 (1955)
Beer, C.T., Richards, J.R.: The metabolism of Vinca alkaloids part II. The fate of tritiated vinblastine in rats. Lloydia 27, 352–360 (1964)
Behnke, O., Forer, A.: Evidence for four classes of microtubules in individual cells. J. Cell Sci. 2, 169–192 (1967)
Bennett, T., Gardiner, S.M.: The effects of intravenous injections of vinblastine or vincristine on the response of the rat heart to nerve stimulation and to drugs. Br. J. Pharmacol. 53, 444 P (1975)
Bensch, K.G., Malawista, S.E.: Microtubule crystals in mammalian cells. J. Cell. Biol. 40, 95–107 (1969)
Bensch, K.G., Marantz, R., Wisniewski, H., Shelanski, M.: Induction in vitro of microtubular crystals by vinca alkaloids. Science 165, 495–496 (1969)
Bhattacharyya, B., Wolff, J.: Tubulin aggregation and disaggregation: mediation by two distinct vinblastine binding sites. Proc. Natl. Acad. Sci. USA 73, 2375–2378 (1976)
Bleyer, W.A., Frisby, S.A., Oliverio, V.T.: Uptake of vincristine by murine leukemia cells. Biochem. Pharmacol. 24, 633–639 (1975)
Blum, R.H., Dawson, D.M.: Vindesine (V) — phase I study of a vinca alkaloid. Proc. Am. Assoc. Cancer Res. 17, 108 (1976)
Bodey, G.P., Freireich, E.J.: Initial clinical studies of vindesine (desacetylvinblastine amide sulfate). Proc. Am. Assoc. Cancer Res. 17, 128 (1976)
Borisy, G.G., Marcum, J.M., Olmsted, J.B., Murphy, D.B., Johnson, K.A.: Purification of tubulin and associated high molecular weight proteins from porcine brain and characterization of microtubule assembly in vitro. Ann. N.Y. Acad. Sci. 253, 107–132 (1975)
Bradley, W.G., Lassman, L.P., Pearce, G.W., Walton, J.N.: The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J. Neurol. Sci. 10, 107–131 (1970)
Bryan, J.: Definition of three classes of binding sites in isolated microtubule crystals. Biochemistry 11, 2611–2616(1972)
Burnside, B.: The form and arrangement of microtubules: an historical, primarily morphological review. Ann. N.Y. Acad. Sci. 253, 14–26 (1975)
Capponi, A.M., Vallotton, M.B.: Renin release by rat kidney slices incubated in vitro. Role of sodium and of alpha- and beta-adrenergic receptors and effect of vincristine. Circ. Res. 39, 200–203 (1976)
Casey, E.B., Fullerton, P.M., Jelliffe, A.W.: Vincristine neurotoxicity: a clinical and electrophysiological study of eighteen patients. Clin. Sci. 38, 23P–24P (1970)
Castle, M.C., Margileth, D.A., Oliverio, V.T.: Distribution and excretion of [3H] vincristine in the rat and the dog. Cancer Res. 36, 3684–3689 (1976)
Chung, L.W.K., Gabourel, J.D.: Adrenal steroid release by vinblastine sulfate and its contributions to vinblastine sulfate effects on rat thymus. Biochem. Pharmacol. 20, 1749–1756 (1971)
Clarkson, B.: Clinical applications of cell cycle kinetics. In: Handbook of experimental pharmacology, Part I. Sartorelli, A.C., Johns, D.G. (eds.), Vol. 38, pp. 156–193. Berlin, Heidelberg, New York: Springer 1974
Cline, M.J.: Effect of vincristine on synthesis of ribonucleic acid and protein in leukaemic leucocytes. Br. J. Haematol. 14, 21–29 (1968)
Cohlan, S.Q., Kitay, D.: The teratogenic effect of vincaleukoblastine in the pregnant rat. J. Pediatr. 66, 541–544 (1965)
Costa, M., Filogamo, G.: Effetti della colchicina nella fibre adrenergiche dei plessi nervosi intestinali. Boll. Soc. Ital. Biol. Sper. 46, 865–867 (1970)
Creasey, W.A.: Tumor-inhibitory effects of combinations of the vinca alkaloids with actinomycin D. Biochem. Pharmacol. 15, 367–375 (1966)
Creasey, W.A.: Modifications in biochemical pathways produced by the vinca alkaloids. Cancer Chemother. Rep. 52, 501–507 (1968)
Creasey, W.A.: Biochemical effects of the vinca alkaloids-IV. Studies with vinleurosine. Biochem. Pharmacol. 18, 227–232 (1969)
Creasey, W.A.: The vinca alkaloids. Biochem. Pharmacol. Suppl. 2, 23, 217–223 (1974)
Creasey, W.A.: Vinca alkaloids and colchicine. In: Handbook of experimental pharmacology, part II. Sartorelli, A.C., Johns, D.G. (eds.), Vol. 38, pp. 670–694. Berlin, Heidelberg, New York: Springer 1975 a
Creasey, W.A.: Biochemistry of dimeric Catharanthus alkaloids. In: The catharanthus alkaloids, botany, chemistry, pharmacology and clinical use. Taylor, W.I., Farnsworth, N.R. (eds.), pp. 209–236. New York: Marcel Dekker 1975b
Creasey, W.A.: Pharmacological considerations in combination chemotherapy. Pharmacol. Ther. A1, 307–325 (1977a)
Creasey, W.A.: Plant alkaloids. In: Cancer: a comprehensive treatise. Becker, F.F. (ed.), Vol. 5, pp. 379–425. New York: Plenum Press 1977b
Creasey, W.A., Markiw, M.E.: Biochemical effects of the vinca alkaloids-I. Effects of vinblastine on nucleic acid synthesis in mouse tumor cells. Biochem. Pharmacol. 13, 135–142 (1964 a)
Creasey, W.A., Markiw, M.E.: Biochemical effects of the vinca alkaloids-II. A comparison of the effects of colchicine, vinblastine and vincristine on the synthesis of ribonucleic acids in Ehrlich ascites carcinoma cells. Biochim. Biophys. Acta 87, 601–609 (1964 b)
Creasey, W.A., Markiw, M.E.: Biochemical effects of the vinca alkaloids-III. The synthesis of ribonucleic acid and the incorporation of amino acids in Ehrlich ascites cells in vitro. Biochem. Biophys. Acta 103, 635–645 (1965)
Creasey, W.A., Bensch, K.G., Malawista, S.E.: Colchicine, vinblastine and griseofulvin. Pharmacological studies with human leukocytes. Biochem. Pharmacol. 20, 1579–1588 (1971)
Creasey, W.A., Scott, A.I., Wei, C.C., Kutcher, J., Schwartz, A., Marsh, J.C.: Pharmacological studies with vinblastine in the dog. Cancer Res. 35, 1116–1120 (1975)
Culpeper, N.: The Complete herbal, 1653. Reprinted for Imperial Chemical Industries. Birmingham: Kynoch Press 1953
Currie, V., Wong, P., Tan, R., Tan, C., Krakoff, I: Preliminary clinical studies of desacetyl vinblastine amide sulfate (DVA), a new vinca alkaloid. Proc. Am. Assoc. Cancer Res. 17, 174 (1976)
Cutts, J.H.: Changes in mitosis in ascites tumors and normal bone marrow induced by vincaleukoblastine in vitro. Can. Cancer Conf. 4, 363–372 (1961)
Cutts, J.H., Beer, C.T., Noble, R.L.: Effects on hematopoiesis in rats of extracts of Vinca rosea. Rev. Can. Biol. 16, 487 (1957)
Cutts, J.H., Beer, C.T., Noble, R.L.: Biological properties of vincaleukoblastine, an alkaloid in Vincarosea Linn., with reference to its antitumor action. Cancer Res. 20, 1023–1031 (1960)
Dahlström, A., Heiwall, P.O., Häggendal, J., Saunders, N.R.: Effect of antimitotic drugs on the intraaxonal transport of neurotransmitters in rat adrenergic and cholinergic nerves. Ann. N.Y. Acad. Sci. 253, 507–516 (1975)
De Conti, R.C., Creasey, W.A.: Clinical aspects of the dimeric Catharanthus alkaloids. In: The catharanthus alkaloids, botany, chemistry, pharmacology and clinical use. Taylor, W.I., Farnsworth, N.R. (eds.), pp. 237–278. New York: Marcel Dekker 1975
De Harven, E.: Action de la colchicine et de certaines hormones corticosurrénaliennes sur les mitoses des follicules pileux du rat. Rev. Belge Pathol. 25, 277 (1956)
Dixon, G.J., Dulmadge, E.A., Mulligan, L.T., Mellett, L.B.: Cell culture bioassay for vincristine sulfate in sera from mice, rats, dogs, and monkeys. Cancer Res. 29, 1810–1813 (1969)
Donigian, D.W., Owellen, R.J.: Interaction of vinblastine, vincristine and colchicine with serum proteins. Biochem. Pharmacol. 22, 2113–2119 (1973)
Donoso, J.A., Green, L.S., Heller-Bettinger, I.E., Samson, F.E.: Action of the Vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine, amide on axonal fibrillar organelles in vitro. Cancer Res. 37, 1401–1407 (1977)
Dustin, P., Jr.: New aspects of the pharmacology of antimitotic agents. Pharmacol. Rev. 15, 449–480 (1963)
Ecknauer, R.: Intestinal absorption of glucose immediately after vincristine administration in rats. Experientia 32, 709–711 (1976)
Eli Lilly & Co.: Compound 99094, desacetyl vinblastine amide sulfate, an investigational new drug. Information for clinical investigators. Indianapolis: Eli Lilly & Co. 1975
Engelborghs, Y., Heremans, K.A.H., De Maeyer, L.C.M., Hoebeke, J.: Effect of temperature and pressure on polymerization equilibrium of neuronal microtubules. Nature (London) 259, 686–688 (1976)
Estridge, M.: Polypeptides similar to the a and β subunits of tubulin are exposed on the neuronal surface. Nature (London) 268, 60–63 (1977)
Farnsworth, N.R., Blomster, R.N., Buckley, J.P.: Catharanthus alkaloids XIII. Antineoplastic and hypotensive activity of alkaloid fractions and certain alkaloids from Catharanthus lanceus. J. Pharm. Sci. 56, 23–27 (1967)
Farnsworth, N.R., Svoboda, G.H., Blomster, R.N.: Antiviral activity of selected Catharanthus alkaloids. J. Pharm. Sci. 57, 2174–2175 (1968)
Ferm, V.H.: Congenital malformations in hamster embryos after treatment with vinblastine and vincristine. Science 141, 426 (1963)
Fine, R.E.: Heterogeneity of tubulin. Nature New Biol. 233, 283–284 (1971)
Fine, R.N., Clarke, R.R., Shore, N.A.: Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion. Am. J. Dis. Child. 112, 256–259 (1966)
Frei, E., III, Gottlieb, J.A.: Combination chemotherapy: Clinical considerations. In: Handbook of experimental pharmacology, part I. Sartorelli, A.C., Johns, D.G. (eds.), Vol. 38, pp. 449–467. Berlin, Heidelberg, New York: Springer 1974
Gailani, S.D., Armstrong, J.G., Carbone, P.P., Tan, C., Holland, J.F.: Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. Cancer Chemother. Rep. 50, 95–103 (1966)
Garcia, F.A.: A botany symposium on medicinal plants. In: Proc. 8th Pacific Sci. Congr. of the Natl. Res. Council of the Philippines, IV[A, 182 (1954)
Gelfand, E.W., Morris, S.A., Resch, K.: Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents. J. Immunol. 114, 919–924 (1975)
George, P., Journey, L.J., Goldstein, M.N.: Effect of vincristine on the fine structure of HeLa cells during mitosis. J. Natl. Cancer Inst. 35, 355–375 (1965)
Gillespie, E., Levine, R.J., Malawista, S.E.: Histamine release from rat peritoneal mast cells: inhibition by colchicine and potentiation by deuterium oxide. J. Pharmacol. Exp. Ther. 164, 158–165 (1968)
Goldfinger, S.E., Howell, R.R., Seegmiller, J.E.: Suppression of metabolic accompaniment of phagocytosis by colchicine. Arthritis Rheum. 8, 1112–1122 (1965)
Goldin, A., Venditti, J.M., Mantel, N.: Combination chemotherapy; Basic considerations. In: Handbook of experimental pharmacology, Part I. Sartorelli, A.C., Johns, D.G. (eds.), Vol. 38, pp. 411–448. Berlin, Heidelberg, New York: Springer 1974
Gottschalk, P.G., Dyck, P.J., Kiely, J.M.: Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. Neurology 18, 875–882 (1968)
Graff, G.L.A., Guening, C., Hildebrand, J.: Action du sulfate de vincristine sur le gastrocnémien de rat I. Mis en evidence de deux compartements, metaboliquement distincts, pour le phosphate inorganique; effets sur les phosphates organiques acidosolubles et les phospholipides. C.R. Soc. Biol. 161, 2645–2651 (1967)
Hancock, B.W., Naysmith, A.: Vincristine-induced autonomie neuropathy. Br. Med. J. 3, 207 (1975)
Hebden, H.F., Hadfield, J.R., Beer, C.T.: The binding of vinblastine by platelets in the rat. Cancer Res. 30, 1417–1424(1970)
Hodes, M.E., Rohn, R.J., Bond, W.H., Yardey, J.: Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn. Cancer Chemother. Rep. 28, 53–55 (1963)
Hunter, J.C.: Effects of vincaleukoblastine sulfate on metabolism of thioguanine-resistant L1210 leukemia cells. Biochem. Pharmacol. 12, 283–291 (1963)
Hwang, Y.F., Hamilton, H.E., Sheets, R.F.: Vinblastine-induced thrombocytosis. Lancet 1969 II, 1075–1076
Johnson, I.S.: Observations on antiviral screening. Ann. N.Y. Acad. Sci. 130, 52–55 (1965)
Johnson, I.S., Wright, H.F., Svoboda, G.H.: Experimental basis for clinical evaluation of anti-tumor principles derived from Vinca rosea Linn. J. Lab. Clin. Med. 54, 830 (1959)
Johnson, I.S., Armstrong, J.G., Gorman, M., Burnett, J.P. Jr.: The vinca alkaloids: A new class of oncolytic agents. Cancer Res. 23, 1390–1427 (1963)
Johnson, I.S., Hargrove, W.W., Harris, P.N., Wright, H.F., Boder, G.B.: Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine. Cancer Res. 26, 2431–2436 (1966)
Jones, R.G.W., Richards, J.F., Beer, C.T.: Biochemical studies with the vinca alkaloids II. Effect of vinblastine on the biosynthesis of nucleic acids and their precursors in rat thymus cells. Cancer Res. 26, 882–887 (1966)
Journey, L.J., Burdman, J., George, P.: Ultrastructural studies on tissue culture cells treated with vincristine (NSC-67574). Cancer Chemother. Rep. 52, 509–517 (1968)
Kingsbury, E.W., Voelz, H.: Induction of helical arrays of ribosomes by vinblastine sulfate in Escherichia coli. Science 166, 768–769 (1969)
Kirschner, M.W., Suter, M., Weingarten, M., Littman, D.: The role of rings in the assembly of microtubules in vitro. Ann. N.Y. Acad. Sci. 253, 90–106 (1975)
Klevecz, R.R., Forrest, G.L.: Regulation of tubulin expression through the cell cycle. Ann. N.Y. Acad. Sci. 253, 292–303 (1975)
Kotorii, K., Mori, H., Yoshida, M.: A peculiar crystalline structure in neurons of rabbits treated with vincristine. Kurume Med. J. 18, 57–63 (1971)
Krakoff, I.H.: Discussion of conference on gout and purine metabolism. Arthritis Rheum. 8, 760 (1965)
Krishan, A.: Time lapse and ultrastructure studies on the reversal of mitotic arrest induced by vinblastine sulfate in Earle’s L. cells. J. Natl. Cancer Inst. 41, 581–595 (1968)
Krishan, A., Frei, E. III: Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. Cancer Res. 35, 497–501 (1975)
Krishan, A., Hsu, D.: Vinblastine-induced ribosomal complexes. Effect of some metabolic inhibitors on their formation and structure. J. Cell Biol. 49, 927–932 (1971)
Krowke, R., Zimmerman, B., Merker, H.J.: Biochemical and electron microscopic studies of rat embryos in in vivo culture. Naunyn Schmiedebergs Arch. Pharmakol. 266, 382–383 (1970)
Kutney, J.P., Gregonis, D.E., Imhof, R., Itoh, I., Jahngen, E.: Absolute sterochemistry of the bisindole alkaloids of the vinblastine type. Circular dichroism studies. J. Am. Chem. Soc. 97, 5013–5015(1975a)
Kutney, J.P., Beck, J., Bylsma, F., Cook, J., Cretney, W.J., Fuji, K., Imhof, R., Tresurywala, A.M.: Total synthesis of indole and dihydroindole alkaloids. VIII. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. The chloroindolenine approach. Helv. Chim. Acta 58, 1690–1719 (1975b)
Lacy, P.E., Howell, S.L., Young, D.A., Fink, C.J.: New hypothesis on insulin secretion. Nature (London) 219, 1177–1179 (1968)
Langlois, N., Gueritte, F., Langlois, Y., Potier, P.: Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J. Am. Chem. Soc. 98, 7017 (1976)
Luyckx, A., Van Lancker, J.L.: Metabolic effects of vinblastine. II. The effect of vinblastine on deoxyribonucleic acid and ribonucleic acid synthesis of regenerating liver. Lab. Invest. 15, 1301–1303 (1966)
Madoc-Jones, H., Mauro, F.: Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J. Cell Physiol. 72, 185–196 (1968)
Malawista, S.E., Sato, H.: Vinblastine produces uniaxial, birefringent crystals in starfish oocytes. J. Cell Biol. 42, 596–599 (1969)
Malawista, S.E., Sato, H., Bensch, K.G.: Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science 160, 770–772 (1968)
Malawista, S.E., Sato, H., Creasey, W.A.: Dissociation of the mitotic spindle in oocytes exposed to griseofulvin and vinblastine. Exp. Cell Res. 99, 193–197 (1976)
Mandelkow, E.M., Mandelkow, E., Unwin, N., Cohen, C.: Tubulin hoops. Nature (London) 265, 655–657 (1977)
Marantz, R., Shelanski, M.: Structure of microtubule crystals induced by vinblastine in vitro. J. Cell Biol. 44, 234–238 (1970)
Mathé, G., Schneider, M., Band, P., Amiel, J.L., Schwarzenberg, L., Cattan, A., Schlumberger, J.R.: Leurosine sulfate (NSC-90636) in treatment of Hodgkin’s disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma. Cancer Chemother. Rep. 49, 47–49 (1965)
McIntosh, J.R., Cande, Z., Snyder, J., Vanderslice, K.: Studies on the mechanism of mitosis. Ann. N.Y. Acad. Sci. 253, 407–427 (1975)
McLeod, J.G., Penny, R.: Vincristine neuropathy: an electrophysiological and histological study. J. Neurol. Neurosurg. Psychiatr. 32, 297–304 (1969)
Miller, J.C., Gutowski, G.E., Poore, G.A., Boder, G.B.: Alkaloids of Vinca rosea L. (Catharanthus roseus G. Don). 38. 4′-Dehydrated derivatives. J. Med. Chem. 20, 409–413 (1977)
Nelson, R.L., Root, M.A., Dyke, R.W., Ahmadzai, S.: Pharmacokinetics of desacetyl vinblastine amide (Vindesine) in man. Proc. Am. Assoc. Cancer Res. 17, 30 (1976)
Neuss, N.A., Barnes, J., Huckstep, L.L.: Vinca alkaloids XXXV. Desacetoxy-vinblastine a new minor alkaloid from Vincarosea L. (Catharanthus roseus G. Don). Experientia 38, 18–20 (1975)
Noble, R.L., Beer, C.T., Cutts, J.H.: Further biological activities of vincaleukoblastine — an alkaloid from Vinca rosea (L). Biochem. Pharmacol. 1, 347–348 (1958)
Noble, R.L., Beer, C.T., McIntyre, R.W.: Biological effects of dihydrovinblastine. Cancer 20, 885–890 (1967)
Nomura, Y., Segawa, T.: Influences of colchicine and vinblastine on the uptake of 5-hydroxytryptamine and norepinephrine by rat brain synaptosomes and small vesicle fractions. J. Neurochem. 24, 1257–1259 (1975)
Obrecht, P., Fusening, N.E.: Die Wirkung von Vincaleukoblastin (Velbe®) auf die Glykolyse von Tumorzellen. Eur. J. Cancer 2, 109–115 (1966)
Ochs, S., Worth, R.: Comparison of the block of fast axoplasmic transport in mammalian nerve by vincristine, vinblastine and desacetyl vinblastine amide (DVA). Proc. Am. Assoc. Cancer Res. 16, 70 (1975)
Olmsted, J.B., Borisy, G.G.: Microtubules. Annu. Rev. Biochem. 42, 507–540 (1973)
Olmsted, J.B., Carlson, K., Klebe, R., Ruddle, F., Rosenbaum, J.L.: Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 65, 129–136 (1970)
Orci, L., Lemarchand, Y., Singh, A., Assimacopoulos-Jennet, F., Rouiller, C.H., Jeanrenaud, B.: Role of microtubules in lipoprotein secretion by the liver. Nature (London) 244, 30–32 (1973)
Owellen, R.J., Donigian, D.W.: [3H] Vincristine. Preparation and preliminary pharmacology. J. Med. Chem. 15, 894–898 (1972)
Owellen, R.J., Hartke, C.A.: The pharmacokinetics of 4-acetyl tritium vinblastine in two patients. Cancer Res. 35, 975–980 (1975)
Owellen, R.J., Hartke, C.A., Dickerson, R.M., Hains, F.O.: Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res. 36, 1499–1502 (1976)
Owellen, R.J., Hartke, C.A., Hains, F.O.: Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res. 37, 2597–2602 (1977a)
Owellen, R.J., Root, M.A., Hains, F.O.: Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 37, 2603–2607 (1977b)
Palmer, C.G., Warren, A.K., Simpson, P.J.: A comparison of the cytologic effects of leurosine methiodide and vinblastine in tissue culture. Cancer Chemother. Rep. 31, 1–2 (1963)
Peckolt, T.: Heil- und Nutzpflanzen Braziliens. Ber. Dtsch. Pharm. Ges. 20, 36–58 (1910)
Richards, J.F., Jones, R.G.W., Beer, C.T.: Biochemical studies with the vinca alkaloids I. Effect on nucleic acid formation by isolated cell suspensions. Cancer Res. 26, 876–881 (1966)
Robertson, J.H., McCarthy, G.M.: Periwinkle alkaloids and the platelet count. Lancet 1969II, 353–355
Roodman, G.D., Hutton, J.J., Bollum, F.J.: DNA polymerase activities during erythropoiesis. Effects of erythropoietin, vinblastine, colcemid, and daunomycin. Exp. Cell Res. 91, 269–278 (1975)
Rosenbaum, J.L., Carlson, K.: Cilia regeneration in Tetrahymema and its inhibition by colchicine. J. Cell Biol. 40, 415–425 (1969)
Sandler, S.G., Tobin, W., Henderson, E.S.: Vincristine-induced neuropathy. A clinical study of fifty leukemia patients. Neurology 19, 367–374 (1969)
Sartorelli, A.C., Creasey, W.A.: Combination chemotherapy. In: Cancer medicine. Holland, J.F., Frei, E. III (eds.), pp. 707–717. Philadelphia: Lea and Febiger 1973
Schmitt, H., Josephs, R., Reisler, E.: A search for in vivo factors in regulation of microtubule assembly. Nature (London) 265, 653–655 (1977)
Schochet, S.S., Lampert, P.W., Earle, K.M.: Neuronal changes induced by intrathecal vincristine sulfate. J. Neuropathol. Exp. Neurol. 27, 645–658 (1968)
Sharma, R.K., Nagcháudhuri, J.: A study of amino acid absorption from small intestines of vinblastine-treated rats with altered mucosal morphology. Indian J. Med. Res. 64, 1225–1234 (1976)
Slater, L.M., Wainer, R.A., Serpick, A.A.: Vincristine neurotoxicity with hyponatremia. Cancer 23, 122–125 (1969)
Slotnick, I.J., Dougherty, M., James, D.H. Jr.: Vincristine inhibition of DNA synthesis in Tetrahymena pyriformis. Cancer Res. 26, 673–675 (1966)
Smith, D.S., Järlfors, V., Cameron, B.F.: Morphological evidence for the participation of microtubules in axonal transport. Ann. N.Y. Acad. Sci. 253, 472–506 (1975)
Soifer, D., Laszlo, A., Mack, K., Scotto, J., Siconolfi, L.: The association of a cyclic AMP-dependent protein kinase activity with microtubule protein. Ann. N.Y. Acad. Sci. 253, 598–610 (1975)
Stearn, W.T.: Synopsis of the genus Catharanthus (Apocynaceae). In: The catharanthus alkaloids, botany, chemistry, pharmacology, and clinical use. Taylor, W.I., Farnsworth, N.R. (eds.), pp. 9–44. New York: Marcel Dekker 1975
Stein, O., Sanger, L., Stein, Y.: Colchicine-induced inhibition of lipoprotein and protein secretion into the serum and lack of interference with secretion of biliary phospholipids and cholesterol by rat liver in vivo. J. Cell Biol. 62, 90–103 (1974)
Stuart, M.J., Cuaso, C., Miler, M., Oski, F.A.: Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. Blood 45, 315–320 (1975)
Svoboda, G.H.: A note on several alkaloids from Vinca rosea Linn. I. Leurosine, virosine and perivine. J. Am. Pharm. Ass. 47, 834 (1958)
Svoboda, G.H.: Alkaloids of Vinca rosea Linn. IX. Extraction and characterization of leurosidine and leurocristine. Lloydia 24, 173–178 (1961)
Svoboda, G.H., Barnes, A.J. Jr.: Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don) XXIV. Vinaspine, vincathicine, rovidine, desacetyl VLB and vinaphamine. J. Pharm. Sci. 53, 1227–1231 (1964)
Svoboda, G.H., Blake, D.A.: The phytochemistry and pharmacology of Catharanthus roseus. In: The catharanthus alkaloids, botany, chemistry, pharmacology, and clinical use. Taylor, W.I., Farnsworth, N.R. (eds.), pp. 45–83. New York: Marcel Dekker 1975
Swerdlow, B., Creasey, W.A.: Binding of vinblastine in vitro to ribosomes of sarcoma 180 cells. Biochem. Pharmacol. 24, 1243–1245 (1975)
Tafur, S., Jones, W.E., Dorman, D.E., Logsdon, E.E., Svoboda, G.H.: Alkaloids of Vinca rosea L. (Catharanthus roseus G. Don) XXXVI. Isolation and characterization of new dimeric alkaloids. J. Pharm. Sci. 64, 1953 (1975)
Teplitz, R.L., Mazie, J.C., Gerson, I., Barr, K.J.: The effects of microtubular binding agents on secretion of IgM antibody. Exp. Cell Res. 90, 392–400 (1975)
Tobin, W.E., Sandler, S.G.: Depression of muscle spindle function with vincristine. Nature (London) 212, 90–91 (1966)
Tobin, W.E., Sandler, S.G.: Neurophysiologic alterations induced by vincristine (NSC-67574). Cancer Chemother. Rep. 52, 519–526 (1968)
Todd, G.C., Gibson, W.R., Griffing, W.J., Morton, D.M.: The preclinical study of desacetyl vinblastine amide (DVA). Proc. Am. Assoc. Cancer Res. 16, 70 (1975)
Ueda, M., Sawadi, M., Kawakami, M., Minesita, T., Takeda, H.: Pressure mechanism of vincristine sulfate. Jpn. J. Pharmacol. 19, 324–325 (1969)
Uy, Q.L., Moen, T.H., Johns, R.J., Owens, A.H. Jr.: Vincristine neurotoxicity in rodents. Johns Hopkins Med. J. 121, 349–360 (1967)
Van Lancker, J.L., Flangas, A.L., Allen, J.: Metabolic effects of vinblastine. I. The effect of vinblastine on nucleic acid synthesis in spleen and bone marrow. Lab. Invest. 15, 1291–1300 (1966)
Vasiliev, J.M., Gelfand, I.M., Guelstein, V.I.: Initiation of DNA synthesis in cell cultures by colcemid. Proc. Natl. Acad. Sci. USA 68, 977–979 (1971)
Venditti, J.M., Abbott, B.J.: Studies on oncolytic agents from natural sources. Correlations of activity against animal tumors and clinical effectiveness. Lloydia 30, 332–348 (1967)
Wagner, E.K., Roizman, B.: Effect of the vinca alkaloids on RNA synthesis in human cells in vitro. Science 162, 569–570 (1968)
Warnecke, P., Seeber, S.: Angriffspunkte von Vinca-Alkaloiden im Protein und Nucleinsäurestoffwechsel. Z. Krebsforsch. 71, 361–367 (1968)
Watt, J.M., Breyer-Brandwijk, M.G.: Medicinal and poisonous plants of Southern and Eastern Africa. p. 85. London: E. & S. Livingston 1962
White, C.T.: Queensl. Agric. J. 23, 143 (1925). Quoted in: Svoboda, G.H., Blake, D.A.: The phytochemistry and pharmacology of Catharanthus roseus. In: The catharanthus alkaloids. Taylor, W.I., Farnsworth, N.R. (eds.), p. 47. New York: Marcel Dekker 1975
Williams, J.A., Lee, M.: Microtubules and pancreatic amylase release by mouse pancreas in vitro. J. Cell Biol. 71, 795–806 (1976)
Wilson, L.: Action of drugs on microtubules. Life Sci. 17, 303–309 (1975a)
Wilson, L.: Microtubules as drug receptors: pharmacological properties of microtubule protein. Ann. N.Y. Acad. Sci. 253, 213–231 (1975b)
Wilson, L., Bryan, J., Ruby, A., Mazia, D.: Precipitation of proteins by vinblastine and calcium ions. Proc. Natl. Acad. Sci. USA 66, 807–814 (1970)
Wolff, J., Bhattacharyya, B.: Microtubules and thyroid hormone mobilization. Ann. N.Y. Acad. Sci. 253, 763–770 (1975)
Yasin, R., Hughes, B.P., Parker, J.A.: The effect of vincristine on the calcium transport and phospholipid composition of rat skeletal muscle microsomes. Lab. Invest. 29, 207–215 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Creasey, W.A. (1979). The Vinca Alkaloids. In: Hahn, F.E. (eds) Mechanism of Action of Antieukaryotic and Antiviral Compounds. Antibiotics, vol 5 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46407-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-46407-2_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46409-6
Online ISBN: 978-3-642-46407-2
eBook Packages: Springer Book Archive